Amorphous Calcium Phosphate NPs Mediate the Macrophage Response and Modulate BMSC Osteogenesis

Area of Science:

• Biomaterials Science
• Immunology
• Regenerative Medicine

Background:

• The biocompatibility and immunomodulatory effects of amorphous calcium phosphate nanoparticles (ACP NPs) require further investigation.
• Understanding the interaction between ACP NPs, immune cells, and bone cells is crucial for developing safe and effective biomaterials.

Purpose of the Study:

• To assess the safety of ACP NPs in macrophages.
• To investigate macrophage responses, including polarization and cytokine secretion, to ACP NPs.
• To evaluate the impact of ACP NP-modulated environments on bone marrow stromal cells (BMSCs) osteogenesis.

Main Methods:

• Cell viability and apoptosis assays (CCK-8, Annexin V).
• Reactive oxygen species (ROS) and autophagy detection (ROS assay, Western blot).
• Macrophage polarization and cytokine analysis (SEM, RT-PCR, ELISA).
• BMSC osteogenic differentiation assessment (ALP, Alizarin Red staining, RT-PCR).

Main Results:

• ACP NPs demonstrated safety in macrophages but induced ROS and autophagy at higher concentrations.
• ACP NPs altered macrophage morphology, promoting M1 polarization and inflammatory cytokine release.
• The ACP NP-macrophage environment significantly inhibited BMSC osteogenic differentiation.

Conclusions:

• ACP NPs can induce aseptic inflammation and M1 macrophage polarization.
• ACP NPs-induced inflammatory microenvironment impairs osteogenesis, potentially affecting bone healing.
• Further research is needed to mitigate these inflammatory effects for clinical applications.